Intellia Therapeutics Inc (NTLA)
23.60
+0.33
(+1.42%)
USD |
NASDAQ |
May 03, 16:00
23.59
-0.01
(-0.04%)
Pre-Market: 20:00
Intellia Therapeutics Revenue (Annual): 36.28M for Dec. 31, 2023
Revenue (Annual) Chart
Historical Revenue (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 36.28M |
| December 31, 2022 | 52.12M |
| December 31, 2021 | 33.05M |
| December 31, 2020 | 57.99M |
| December 31, 2019 | 43.10M |
| Date | Value |
|---|---|
| December 31, 2018 | 30.43M |
| December 31, 2017 | 26.12M |
| December 31, 2016 | 16.48M |
| December 31, 2015 | 6.044M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
33.05M
Minimum
2021
57.99M
Maximum
2020
44.51M
Average
43.10M
Median
2019
Revenue (Annual) Benchmarks
| Moderna Inc | 6.754B |
| Regeneron Pharmaceuticals Inc | 13.12B |
| NeuroMetrix Inc | 5.901M |
| Repligen Corp | 638.76M |
| Pacific Biosciences of California Inc | 200.52M |